Skip to content
OpenCapital
Get started

OrthoPediatrics KIDS EPS (Diluted)

EPS (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.14-52.9%
Stryker logo
StrykerSYK
$1.93+14.2%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$0.52+61.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$1.22+34.1%
Medtronic logo
MedtronicMDT
$0.97+18.3%
Alphatec Holdings logo
Alphatec HoldingsATEC
-$0.22+37.1%

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0×0.0×
Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's EPS (diluted)?
OrthoPediatrics (KIDS) reported EPS (diluted) of -$0.45 in Q1 2026.
How has OrthoPediatrics's EPS (diluted) changed year-over-year?
OrthoPediatrics's EPS (diluted) increased by 2.2% year-over-year, from -$0.46 to -$0.45.
What is the long-term trend for OrthoPediatrics's EPS (diluted)?
Over 3 years (2021 to 2025), OrthoPediatrics's EPS (diluted) has grown at a 26.2% compound annual growth rate (CAGR), from -$0.84 to -$1.69.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.